Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan

Drug and Alcohol Dependence

Volumn 111, Issue 3, 2010, Pages 235-240

  McCarty, Dennis ^a   Perrin, Nancy A ^b   Green, Carla A ^b   Polen, Michael R ^b   Leo, Michael C ^a   Lynch, Frances ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Commercial health insurance; Cost analysis; Health care utilization; Methadone maintenance; Parity

Indexed keywords

METHADONE;

ADULT; ARTICLE; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; OUTPATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; DELIVERY OF HEALTH CARE; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREPAID HEALTH PLANS;

EID: 77957323617     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.04.018     Document Type: Article

References (18)

1. Barnett P.G. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 1994, 94:479-488.
2. Dijkgraff M.G.W., van der Zanden B.P., de Borgie C., Blanken P., van Ree J.M., van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Br. Med. J. 2005, 330:1-6.
3. Dole V.P., Nyswander M.A. Medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 1965, 193:646-650.
4. Doran C.M., Shanahan M., Mattick R.P., Ali R., White J., Bell J. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend. 2003, 71:295-302.
5. Harris A.H., Gospodarevskaya E., Ritter A.J. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 2005, 23:77-91.
6. Hurtado A.V., Greenlick M.R. A disease classification system for analysis of medical care utilization, with a note on symptom classification. Health Serv. Res. 1971, 6:235-250.
7. Kleber H.D. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA 2008, 300:2303-2305.
8. Kraemer H.C., Morgan G.A., Leech N.L., Gliner J.A., Vaske J.J., Harmon R.J. Measures of clinical significance. J. Am. Acad. Child Adolesc. Psychiatr. 2003, 42:1524-1529.
9. Laine C., Hauck W.W., Gourevitch M.N., Rothman J., Cohen A., Turner B.J. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA 2001, 285:2355-2362.
10. Lowinson J.H., Marion I., Joseph H., Langrod J., Salsitz E.A., Payte J.T., Dole V.P. Methadone maintenance. Substance Abuse: A Comprehensive Textbook 2005, 616-633. Lippincott Williams & Wilkins, Philadelphia, PA. 4th ed. J.H. Lowinson, P. Ruiz, R.B. Millman, J.G. Langrod (Eds.).
11. Masson C.L., Sorenson J.L., Batki S.L., Okin R., Delucchi K.L., Perlman D.C. Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend. 2002, 66:45-50.
12. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence (Review). Cochrane Libr. 2009, 1-33.
13. McCarty D., Frank R., Denmead G. Methadone maintenance and state Medicaid managed care programs. Milbank Q. 1999, 77:341-362.
14. Effective medical treatment of opiate addiction. JAMA 1998, 280:1936-1943. National Consensus Development Panel on Effective Treatment of Opiate Addiction.
15. Simeons S., Ludbrook A., Matheson C., Bond C. Pharmacoeconomics of community maintenance for opiate dependence: a review of evidence and methodology. Drug Alcohol Depend. 2006, 84:28-39.
16. Stein M.D., Anderson B. Injection frequency mediates health service use among persons with a history of drug injection. Drug Alcohol Depend. 2003, 70:159-168.
17. White A.G., Birnbaum H.G., Mareva M.N., Daher M., Vallow S., Schein J., Katz N. Direct costs of opioid abuse in an insured population in the United States. J. Manage. Care Pharm. 2005, 11:469-479.
18. Zaric G.S., Barnett P.G., Brandeau M.L. HIV transmission and the cost-effectiveness of methadone maintenance. Am. J. Public Health 2000, 90:1100-1111.